Sanofi vaccine against Covid-19 now has a date, it will be available ” in December “. The technology of the latter differs from existing vaccines, since it is a recombinant protein technology, the technology used for influenza vaccination.
Asked this Monday, July 5 about France Inter, Olivier Bogillo, the president of the Sanofi group, announced that the French vaccine should be available before the end of the year. Neither adenovirus nor messenger RNA, Sanofi’s vaccine relies on technology “Proven” recombinant proteins. A technology that has been around for years, also used in the manufacture of the influenza vaccine. “This is the technology that was the most efficient a year ago! This recombinant protein, with an adjuvant, it stimulates your immune system, it subjects it to the virus protein, and it makes you react. This type of vaccine will be added to existing vaccines from Pfizer, Moderna or AstraZeneca “, explains Olivier Bogillo.
“Today, only 20% of the world’s population is vaccinated”
There is no shortage of vaccines and the majority of French people in favor of vaccination will have already received their dose (s) by December. So what will this new candidate be used for? “Today, only 20% of the world’s population is vaccinated. We think that we can be useful because it takes billions of doses to be able to vaccinate this world population ”, underlined Olivier Bogillot. Regarding non-vaccinated French people, “I think we have to continue to explain, to give information, to be very transparent. Confidence comes with transparency: all the data are available today, the vaccines are effective and have few side effects ”, explains Olivier Bogillo.
“We are the country of Pasteur, we are the country which discovered vaccination… Vaccination is after drinking water which has saved the most people in the world, the most lives. We vaccinate our children at school, vaccination is something that protects us, that protects others. Vaccination saves lives! I encourage people to have confidence “, he adds.
